We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Hepatic Artery Catheterization for Chemotherapy

Jean J. Labelle, MD; Robert J. Lucas, MD; Bernard Eisenstein, MD; Melvin D. Reed, MD; Vainutis K. Vaitkevicius, MD; Gerald S. Wilson, MD
Arch Surg. 1968;96(4):683-692. doi:10.1001/archsurg.1968.01330220199029.
Text Size: A A A
Published online


CHEMOTHERAPY now is one of the accepted modes of treatment of metastatic tumor. Systemic administration of the chemotherapeutic agent has the distinct disadvantage of being toxic to normal tissues, particularly bone marrow, thus decidedly curtailing the concentration of drug that can be delivered to the tumor tissue. As first demonstrated by Klopp et al1 and later confirmed by others,2-10 in instances in which one organ is involved and the arterial supply can be isolated, the general deleterious effects of the drug can be reduced by delivering a high concentration to the organ over a fairly long period of time through its arterial blood supply, thus providing a constant bombardment of antimetabolites to the reproducing neoplastic cells. This method of therapy is termed "infusion," in contrast to "perfusion" in which the arterial and venous supply of the tumor-laden area, usually an extremity, is isolated from the general circulation and


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.